Generate Biomedicines, Inc. (GENB)
17.71
+1.59
(+9.86%)
USD |
NASDAQ |
Aug 24, 16:00
17.62
-0.09
(-0.51%)
After-Hours: 20:00
Generate Biomedicines Net Income (Quarterly) : -67.26M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -67.26M |
| March 31, 2026 | -61.71M |
| Date | Value |
|---|---|
| June 30, 2025 | -56.74M |
| March 31, 2025 | -44.31M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Twist Bioscience Corp. | -35.05M |
| Prime Medicine, Inc. | -42.11M |
| Intellia Therapeutics, Inc. | -106.63M |
| Beam Therapeutics, Inc. | -122.68M |
| Moderna, Inc. | -782.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 6.314M |
| Total Expenses (Quarterly) | 73.57M |
| EPS Diluted (Quarterly) | -0.5243 |
| Enterprise Value | 1.673B |
| Gross Profit Margin (Quarterly) | 48.94% |
| Profit Margin (Quarterly) | -1.07K% |
| Earnings Yield | -26.08% |
| Normalized Earnings Yield | -26.07 |